Drug name - Tricor
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7320802 | ABBVIE | Methods of treatment using nanoparticulate fenofibrate compositions |
Feb, 2023
(4 months from now) | |
| US7276249 | ABBVIE | Nanoparticulate fibrate formulations |
Feb, 2023
(4 months from now) | |
Drugs and Companies using FENOFIBRATE ingredient
Treatment: Adjunctive therapy to diet in adults to reduce ldl-c, triglycerides and apo b, and increase hdl-c in patients with primary hypercholesterolemia or mixed dyslipidemia (types iia, iib) and to treat hypertriglyceridemia (types iv, v)
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 48MG | TABLET;ORAL | Prescription |
| 145MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.